XML 62 R48.htm IDEA: XBRL DOCUMENT v3.22.1
Common Stock and Stock-Based Compensation (Tables)
12 Months Ended
Mar. 25, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of Stock Issued in Common Stock Conversion
The following table presents the respective number of shares of common stock and unvested restricted common stock issued in the Common Stock Conversion. The number of shares of common stock and unvested restricted common stock issuable are based upon the vesting provisions of the outstanding shares and reflect the shares vested and unvested at the date of conversion.
Shares of
Common Stock
Shares of Unvested
Restricted
Common Stock
Total Shares of
Common Stock
Class A common stock156,155,403 — 156,155,403 
Class L common stock7,816,614 459,749 8,276,363 
Total163,972,017 459,749 164,431,766 
Schedule of Restricted Stock Units Activity
The following table summarizes RSU activity for the fiscal years ended March 25, 2022 and March 26, 2021:
Number of
Shares
Weighted-Average Grant-Date Fair ValueWeighted-Average Remaining Contractual Life
(In years)
Aggregate
Intrinsic
Value
Outstanding - March 27, 2020— $— — $— 
Granted 1,428,932 14.06 
Vested(160,063)14.00 
Canceled(43,713)14.00 
Outstanding - March 26, 20211,225,156 $14.07 1.70$30,960 
Granted1,344,717 26.00 
Vested(622,508)20.33 
Canceled(246,358)19.02 
Outstanding - March 25, 20221,701,007 $20.50 1.27$49,635 
Schedule of Performance Units Fair Value Assumptions
The weighted-average fair value of the PSUs was determined using the Monte Carlo simulation model incorporating the following weighted-average assumptions:
Fiscal Year Ended
March 26,
2021
Performance term2.42 years
Volatility49.9%
Risk-free rate of return0.17%
Dividend yield—%
Weighted-average fair value per share$14.00
Summary of Performance Stock Units Activity
The following table summarizes PSU activity for the fiscal years ended March 25, 2022 and March 26, 2021:
Number of
Shares
Weighted-Average Grant-Date Fair ValueWeighted-Average Remaining Contractual Life
(In years)
Aggregate
Intrinsic
Value
Outstanding - March 27, 2020— $— — $— 
Granted650,302 15.05 
Vested— — 
Canceled— — 
Outstanding - March 26, 2021650,302 $15.05 2.65$16,433 
Granted465,732 27.08 
Vested— — 
Canceled(160,951)19.19 
Outstanding - March 25, 2022955,083 $20.22 1.51$27,869 
Summary of Unvested Restricted Common Stock Activity
The following table summarizes unvested restricted common stock activity for the fiscal years ended March 25, 2022 and March 26, 2021:
Number of
Shares
Weighted-Average Grant-Date Fair ValueWeighted-Average Remaining Contractual LifeAggregate
Intrinsic
Value
Outstanding - March 27, 2020— — — — 
Common stock conversion459,749 14.00 
Vested(50,170)14.00 
Canceled(3,252)14.00 
Outstanding - March 26, 2021406,327 $14.00 1.79$— 
Vested(241,787)14.00 
Canceled(24,014)— 
Outstanding - March 25, 2022140,526 $14.00 1.07$4,101 
Schedule of Stock-Based Compensation Expense The Company recorded stock-based compensation expense in the following expense categories of its consolidated statements of operations:
Fiscal Year Ended
March 25,
2022
March 26,
2021
March 27,
2020
Cost of sales$3,176 $5,158 $183 
Research and development3,933 3,573 87 
Selling, general and administrative26,439 41,139 1,165 
Total stock-based compensation$33,548 $49,870 $1,435 
Schedule of ESPP Fair Value Assumptions
The weighted-average fair value of the ESPP shares was determined using the Black-Scholes model incorporating the following weighted-average assumptions:
Fiscal Year Ended
March 25,
2022
March 26,
2021
Performance term0.50 years0.50 years
Volatility48.10%55.02%
Risk-free rate of return0.10%0.09%
Dividend yield—%—%
Weighted-average fair value per share$8.25$7.77